Search research articles
Contact Us
Filters
Showing results (721-730 of 824) with videos related to
Page
of 83
Sort By:
Journal of the American Chemical Society
|
September 16, 2011
Lysine-specific molecular tweezers are broad-spectrum inhibitors of assembly and toxicity of amyloid proteins
Sharmistha Sinha, Dahabada H J Lopes, Zhenming Du, et al.
Oncogene
|
April 6, 2004
Epstein-Barr virus latent membrane protein 1 (LMP1) upregulates Id1 expression in nasopharyngeal epithelial cells
H M Li, Z H Zhuang, Q Wang, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society
|
October 8, 2017
Relationship between baseline systolic blood pressure and long-term outcomes in acute heart failure patients treated with TRV027: an exploratory subgroup analysis of BLAST-AHF
Gad Cotter, Beth A Davison, Javed Butler, et al.
Hepatology (Baltimore, Md.)
|
November 9, 2015
Safety and efficacy of ledipasvir-sofosbuvir in black patients with hepatitis C virus infection: A retrospective analysis of phase 3 data
Julius M Wilder, Lennox J Jeffers, Natarajan Ravendhran, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 2, 2015
Successful Retreatment of Chronic HCV Genotype-1 Infection With Ledipasvir and Sofosbuvir After Initial Short Course Therapy With Direct-Acting Antiviral Regimens
Eleanor M Wilson, Sarah Kattakuzhy, Sreetha Sidharthan, et al.
JAMA Network Open
|
January 10, 2024
Short-Stay Units vs Routine Admission From the Emergency Department in Patients With Acute Heart Failure: The SSU-AHF Randomized Clinical Trial
Peter S Pang, David A Berger, Simon A Mahler, et al.
Gastroenterology
|
June 15, 2016
Prevalence of Resistance-Associated Substitutions in HCV NS5A, NS5B, or NS3 and Outcomes of Treatment With Ledipasvir and Sofosbuvir
Christoph Sarrazin, Hadas Dvory-Sobol, Evguenia S Svarovskaia, et al.
Cancer Management and Research
|
March 19, 2019
Interferon α-inducible protein 27 is an oncogene and highly expressed in cholangiocarcinoma patients with poor survival
Kun-Chun Chiang, Sheng-Teng Huang, Ren-Chin Wu, et al.
Heart Failure Reviews
|
May 15, 2012
Current management and future directions for the treatment of patients hospitalized for heart failure with low blood pressure
Mihai Gheorghiade, Muthiah Vaduganathan, Andrew Ambrosy, et al.
Anticancer Research
|
March 27, 2026
Analysis of Clinical Benefit Using DNG64-<i>CAR-V</i> Chimeric Tumor Targeted Amphotropic RNA Vector in <i>CCNG1</i> Expressing Cancers
Sant P Chawla, Samantha Jeffrey, Skyler S Pang, et al.
Page
of 83
Search research articles
Search
Showing results (721-730 of 824) with videos related to
Sort By:
Page
of 83
Journal of the American Chemical Society
|
September 16, 2011
Lysine-specific molecular tweezers are broad-spectrum inhibitors of assembly and toxicity of amyloid proteins
Sharmistha Sinha, Dahabada H J Lopes, Zhenming Du, et al.
Oncogene
|
April 6, 2004
Epstein-Barr virus latent membrane protein 1 (LMP1) upregulates Id1 expression in nasopharyngeal epithelial cells
H M Li, Z H Zhuang, Q Wang, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society
|
October 8, 2017
Relationship between baseline systolic blood pressure and long-term outcomes in acute heart failure patients treated with TRV027: an exploratory subgroup analysis of BLAST-AHF
Gad Cotter, Beth A Davison, Javed Butler, et al.
Hepatology (Baltimore, Md.)
|
November 9, 2015
Safety and efficacy of ledipasvir-sofosbuvir in black patients with hepatitis C virus infection: A retrospective analysis of phase 3 data
Julius M Wilder, Lennox J Jeffers, Natarajan Ravendhran, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 2, 2015
Successful Retreatment of Chronic HCV Genotype-1 Infection With Ledipasvir and Sofosbuvir After Initial Short Course Therapy With Direct-Acting Antiviral Regimens
Eleanor M Wilson, Sarah Kattakuzhy, Sreetha Sidharthan, et al.
JAMA Network Open
|
January 10, 2024
Short-Stay Units vs Routine Admission From the Emergency Department in Patients With Acute Heart Failure: The SSU-AHF Randomized Clinical Trial
Peter S Pang, David A Berger, Simon A Mahler, et al.
Gastroenterology
|
June 15, 2016
Prevalence of Resistance-Associated Substitutions in HCV NS5A, NS5B, or NS3 and Outcomes of Treatment With Ledipasvir and Sofosbuvir
Christoph Sarrazin, Hadas Dvory-Sobol, Evguenia S Svarovskaia, et al.
Cancer Management and Research
|
March 19, 2019
Interferon α-inducible protein 27 is an oncogene and highly expressed in cholangiocarcinoma patients with poor survival
Kun-Chun Chiang, Sheng-Teng Huang, Ren-Chin Wu, et al.
Heart Failure Reviews
|
May 15, 2012
Current management and future directions for the treatment of patients hospitalized for heart failure with low blood pressure
Mihai Gheorghiade, Muthiah Vaduganathan, Andrew Ambrosy, et al.
Anticancer Research
|
March 27, 2026
Analysis of Clinical Benefit Using DNG64-<i>CAR-V</i> Chimeric Tumor Targeted Amphotropic RNA Vector in <i>CCNG1</i> Expressing Cancers
Sant P Chawla, Samantha Jeffrey, Skyler S Pang, et al.
Page
of 83